Kindred Biosciences, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Cash Flows from Operating Activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Shares issued for consulting services
Depreciation and amortization expense
Loss on disposal of property and equipment
Amortization of discount on marketable securities
Amortization of debt discount of loan payable
Finished goods write off related to Dechra agreements
Changes in operating assets and liabilities:
Accounts, royalty and license receivable
Inventories
Prepaid expenses and other
Other assets
Accounts payable
Accrued liabilities and accrued compensation
Net cash used in operating activities
Cash Flows from Investing Activities
Purchases of investments
Sales of investments
Maturities of investments
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash provided by (used in) investing activities
Cash Flows from Financing Activities
Exercise of stock options and purchase of ESPP shares
Proceeds from loan payable, net of issuance costs
Payment of restricted stock awards tax liability on net settlement
Net proceeds from sales of common stock
Net cash (used in) provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosure of non-cash financing activities:
Issuance of common stock and stock options for accrued consulting expenses
Common Stock
Total issuance of common stock and stock options for accrued consulting expenses

Purchases of property and equipment included in accounts payable and accrued liabilities
Proceeds due from exercise of stock options

Comments